FRAX and the effect of teriparatide on vertebral and non-vertebral fracture
Background: daily administration of 20µg or 40µg teriparatide has been shown to significantly decrease the risk of vertebral and non-vertebral fracture compared with placebo. The aim of the present study was to evaluate fracture risk assessed at baseline using the FRAX® tool and to determine the eff...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2015-05-10.
|
| Subjects: | |
| Online Access: | Get fulltext |